Latest News about ARGX
Recent news which mentions ARGX
65 Biggest Movers From Yesterday
December 21, 2021
From Benzinga
38 Stocks Moving In Monday's Mid-Day Session
December 20, 2021
From Benzinga
Is Argenx a Good Biotech Stock to Buy for 2022?
December 20, 2021
From Motley Fool
Argenx's Vyvgart Wins FDA Approval For Autoimmune, Neuromuscular Disease
December 20, 2021
From Benzinga
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 4%
December 20, 2021
From Benzinga
5 Stocks To Watch For December 20, 2021
December 20, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
December 19, 2021
From Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
From Benzinga
2 Mid-Cap Biopharma Stocks BofA Securities Recommends For 2022
December 14, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
November 29, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
November 29, 2021
From Benzinga
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
October 29, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 29, 2021
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
October 19, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
From Benzinga
Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley
September 07, 2021
From MarketWatch